781 related articles for article (PubMed ID: 23325320)
21. Bim contributes to the progression of Huntington's disease-associated phenotypes.
Roberts SL; Evans T; Yang Y; Fu Y; Button RW; Sipthorpe RJ; Cowan K; Valionyte E; Anichtchik O; Li H; Lu B; Luo S
Hum Mol Genet; 2020 Jan; 29(2):216-227. PubMed ID: 31813995
[TBL] [Abstract][Full Text] [Related]
22. Compartment-Dependent Degradation of Mutant Huntingtin Accounts for Its Preferential Accumulation in Neuronal Processes.
Zhao T; Hong Y; Li S; Li XJ
J Neurosci; 2016 Aug; 36(32):8317-28. PubMed ID: 27511006
[TBL] [Abstract][Full Text] [Related]
23. Golgi protein ACBD3 mediates neurotoxicity associated with Huntington's disease.
Sbodio JI; Paul BD; Machamer CE; Snyder SH
Cell Rep; 2013 Sep; 4(5):890-7. PubMed ID: 24012756
[TBL] [Abstract][Full Text] [Related]
24. Reversal of cellular phenotypes in neural cells derived from Huntington's disease monkey-induced pluripotent stem cells.
Carter RL; Chen Y; Kunkanjanawan T; Xu Y; Moran SP; Putkhao K; Yang J; Huang AH; Parnpai R; Chan AW
Stem Cell Reports; 2014 Oct; 3(4):585-93. PubMed ID: 25358787
[TBL] [Abstract][Full Text] [Related]
25. Proteomics of Huntington's disease-affected human embryonic stem cells reveals an evolving pathology involving mitochondrial dysfunction and metabolic disturbances.
McQuade LR; Balachandran A; Scott HA; Khaira S; Baker MS; Schmidt U
J Proteome Res; 2014 Dec; 13(12):5648-59. PubMed ID: 25316320
[TBL] [Abstract][Full Text] [Related]
26. Human-to-mouse prion-like propagation of mutant huntingtin protein.
Jeon I; Cicchetti F; Cisbani G; Lee S; Li E; Bae J; Lee N; Li L; Im W; Kim M; Kim HS; Oh SH; Kim TA; Ko JJ; Aubé B; Oueslati A; Kim YJ; Song J
Acta Neuropathol; 2016 Oct; 132(4):577-92. PubMed ID: 27221146
[TBL] [Abstract][Full Text] [Related]
27. Heat shock promotes inclusion body formation of mutant huntingtin (mHtt) and alleviates mHtt-induced transcription factor dysfunction.
Chen JY; Parekh M; Seliman H; Bakshinskaya D; Dai W; Kwan K; Chen KY; Liu AYC
J Biol Chem; 2018 Oct; 293(40):15581-15593. PubMed ID: 30143534
[TBL] [Abstract][Full Text] [Related]
28. Advances in huntington disease drug discovery: novel approaches to model disease phenotypes.
Bard J; Wall MD; Lazari O; Arjomand J; Munoz-Sanjuan I
J Biomol Screen; 2014 Feb; 19(2):191-204. PubMed ID: 24196395
[TBL] [Abstract][Full Text] [Related]
29. Aggregation in Huntington's disease: insights through modelling.
Cajavec B; Bernard S; Herzel H
Genome Inform; 2005; 16(1):262-71. PubMed ID: 16362929
[TBL] [Abstract][Full Text] [Related]
30. Calretinin interacts with huntingtin and reduces mutant huntingtin-caused cytotoxicity.
Dong G; Gross K; Qiao F; Ferguson J; Callegari EA; Rezvani K; Zhang D; Gloeckner CJ; Ueffing M; Wang H
J Neurochem; 2012 Nov; 123(3):437-46. PubMed ID: 22891683
[TBL] [Abstract][Full Text] [Related]
31. Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons.
Kraft AD; Kaltenbach LS; Lo DC; Harry GJ
Neurobiol Aging; 2012 Mar; 33(3):621.e17-33. PubMed ID: 21482444
[TBL] [Abstract][Full Text] [Related]
32. Drugging unconventional targets: insights from Huntington's disease.
Yu S; Liang Y; Palacino J; Difiglia M; Lu B
Trends Pharmacol Sci; 2014 Feb; 35(2):53-62. PubMed ID: 24388390
[TBL] [Abstract][Full Text] [Related]
33. The ubiquitin conjugating enzyme Ube2W regulates solubility of the Huntington's disease protein, huntingtin.
Wang B; Zeng L; Merillat SA; Fischer S; Ochaba J; Thompson LM; Barmada SJ; Scaglione KM; Paulson HL
Neurobiol Dis; 2018 Jan; 109(Pt A):127-136. PubMed ID: 28986324
[TBL] [Abstract][Full Text] [Related]
34. Rescue of aberrant huntingtin palmitoylation ameliorates mutant huntingtin-induced toxicity.
Lemarié FL; Caron NS; Sanders SS; Schmidt ME; Nguyen YTN; Ko S; Xu X; Pouladi MA; Martin DDO; Hayden MR
Neurobiol Dis; 2021 Oct; 158():105479. PubMed ID: 34390831
[TBL] [Abstract][Full Text] [Related]
35. Mutant huntingtin expression in microglia is neither required nor sufficient to cause the Huntington's disease-like phenotype in BACHD mice.
Petkau TL; Hill A; Connolly C; Lu G; Wagner P; Kosior N; Blanco J; Leavitt BR
Hum Mol Genet; 2019 May; 28(10):1661-1670. PubMed ID: 30624705
[TBL] [Abstract][Full Text] [Related]
36. Modulation of mitochondrial function by stem cell-derived cellular components.
Liu T; Im W; Lee ST; Ban JJ; Chai YJ; Lee M; Mook-Jung I; Chu K; Kim M
Biochem Biophys Res Commun; 2014 Jun; 448(4):403-8. PubMed ID: 24802395
[TBL] [Abstract][Full Text] [Related]
37. Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice.
Vodicka P; Chase K; Iuliano M; Valentine DT; Sapp E; Lu B; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M
J Huntingtons Dis; 2016 Jun; 5(2):163-74. PubMed ID: 27314618
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
39. TR-FRET-based duplex immunoassay reveals an inverse correlation of soluble and aggregated mutant huntingtin in huntington's disease.
Baldo B; Paganetti P; Grueninger S; Marcellin D; Kaltenbach LS; Lo DC; Semmelroth M; Zivanovic A; Abramowski D; Smith D; Lotz GP; Bates GP; Weiss A
Chem Biol; 2012 Feb; 19(2):264-75. PubMed ID: 22365609
[TBL] [Abstract][Full Text] [Related]
40. Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo.
Graham RK; Deng Y; Carroll J; Vaid K; Cowan C; Pouladi MA; Metzler M; Bissada N; Wang L; Faull RL; Gray M; Yang XW; Raymond LA; Hayden MR
J Neurosci; 2010 Nov; 30(45):15019-29. PubMed ID: 21068307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
